Kobayashi Pharmaceutical Co., Ltd.
KBYPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,782,500 | $400,601,898 | $417,236,180 | $437,716,131 |
| - Cash | $306,045 | $56,288,000 | $52,405,000 | $50,873,000 |
| + Debt | $4,759 | $749,000 | $789,000 | $846,000 |
| Enterprise Value | $2,481,214 | $345,062,898 | $365,620,180 | $387,689,131 |
| Revenue | $290,815 | $36,411,000 | $32,607,000 | $51,141,000 |
| % Growth | -99.2% | 11.7% | -36.2% | – |
| Gross Profit | $151,255 | $19,462,000 | $16,683,000 | $24,907,000 |
| % Margin | 52% | 53.5% | 51.2% | 48.7% |
| EBITDA | $48,604 | $6,325,000 | $4,485,500 | $8,645,500 |
| % Margin | 16.7% | 17.4% | 13.8% | 16.9% |
| Net Income | $24,627 | $1,543,000 | $1,624,000 | $4,723,000 |
| % Margin | 8.5% | 4.2% | 5% | 9.2% |
| EPS Diluted | 0.33 | 20.76 | 21.85 | 63.53 |
| % Growth | -98.4% | -5% | -65.6% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |